The Spectrum of Neurological Manifestations of Varicella–Zoster Virus Reactivation
Abstract
:1. Introduction: The Problem of VZV Reactivation
2. The Role of Immunosuppression in VZV Reactivation
3. Herpes Zoster
4. Post-Herpetic Neuralgia (PHN)
5. VZV Vasculopathy
6. Giant Cell Arteritis
7. Encephalitis
8. Segmental Motor Weakness
9. Zoster Sine Herpete
10. Cranial Neuropathies
11. Other Neurological Manifestations
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Kennedy, P.G.E.; Gershon, A.A. Clinical features of Varicella-Zoster virus infection of the nervous system. Viruses 2018, 10, 609. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kennedy, P.G.E.; Grinfeld, E.; Gow, J.W. Latent varicella–zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc. Natl. Acad. Sci. USA 1998, 95, 4658–4662. [Google Scholar] [CrossRef]
- Gershon, A.A.; Breuer, J.; Cohen, J.I.; Cohrs, R.J.; Gershon, M.D.; Gilden, D.; Grose, C.; Hambleton, S.; Kennedy, P.G.E.; Oxman, M.; et al. Varicella zoster virus infection. Nat. Rev. Dis. Prim. 2015, 1, 15016. [Google Scholar] [CrossRef] [Green Version]
- Kennedy, P.G.E.; Rovnak, J.; Badani, H.; Cohrs, R.J. A comparison of herpes simplex virus type 1 andvaricella-zoster virus latency and reactivation. J. Gen. Virol. 2015, 96 Pt 7, 1581–1602. [Google Scholar] [CrossRef]
- Cohrs, R.J.; Barbour, M.; Gilden, D.H. Varicella-zoster virus (VZV) transcription during latency in human ganglia: Detection of transcripts to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Virol. 1996, 70, 2789–2796. [Google Scholar] [CrossRef]
- Kennedy, P.G.E.; Grinfeld, E.; Bell, J.E. Varicella-Zoster Virus Gene Expression in Latently Infected and Explanted Human Ganglia. J. Virol. 2000, 74, 11893–11898. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cohrs, R.J.; Gilden, D.H.; Kinchington, P.R.; Grinfeld, E.; Kennedy, P.G.E. Varicella-Zoster Virus Gene 66 Transcription and Translation in Latently Infected Human Ganglia. J. Virol. 2003, 77, 6660–6665. [Google Scholar] [CrossRef] [Green Version]
- Depledge, D.P.; Ouwendijk, W.J.D.; Sadaoka, T.; Braspenning, S.E.; Mori, Y.; Cohrs, R.J.; Verjans, G.M.G.M.; Breuer, J. A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61. Nat. Commun. 2018, 9, 1167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ouwendijk, W.J.D.; Depledge, D.P.; Rajbhandari, L.; Rovis, T.L.; Jonjic, S.; Breuer, J.; Venkatesan, A.; Verjans, G.M.G.M.; Sadaoka, T. Varicella-zoster virus VLT-ORF63 fusion transcript induces broad viral gene expression during reactivation from neuronal latency. Nat. Commun. 2020, 11, 6324. [Google Scholar] [CrossRef]
- Kennedy, P.G.E.; Mogensen, T.H.; Cohrs, R.J. Recent Issues in Varicella-Zoster Virus Latency. Viruses 2021, 13, 2018. [Google Scholar] [CrossRef]
- Kennedy, P.G.E.; Mogensen, T.H. Determinants of neurological syndromes caused by varicella zoster virus (VZV). J. Neuro Virol. 2020, 26, 482–495. [Google Scholar] [CrossRef] [PubMed]
- Bezrodnik, L.; Di Giovanni, D.; Caldirola, M.S.; Azcoiti, M.E.; Torgerson, T.; Gaillard, M.I. Long-term follow-up of STAT5B deficiency inthree argentinian patients: Clinical and immunological features. J. Clin. Immunol. 2015, 35, 264–272. [Google Scholar] [CrossRef] [PubMed]
- Carter-Timofte, M.E.; Hansen, A.F.; Mardahl, M.; Fribourg, S.; Rapaport, F.; Zhang, S.Y.; Casanova, J.L.; Paludan, S.R.; Christiansen, M.; Larsen, C.S.; et al. Varicella-zoster virus CNS vasculitis and RNA polymerase III gene mutation in identical twins. Neurol. Neuroimmunol. Neuroinflamm. 2018, 5, e500. [Google Scholar] [CrossRef] [Green Version]
- Hope-Simpson, R.E. The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis. Proc. R. Soc. Med. 1965, 58, 9–20. [Google Scholar] [CrossRef] [PubMed]
- Ragozzino, M.W.; Melton, L.J., 3rd; Kurland, L.T.; Chu, C.P.; Perry, H.O. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982, 61, 310–316. [Google Scholar] [CrossRef]
- Wareham, D.W.; Breuer, J. Herpes zoster. Brit. Med. J. 2007, 334, 1211–1215. [Google Scholar] [CrossRef]
- Harpaz, R.; Leung, J.W. The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns among Older Adults. Clin. Infect. Dis. 2019, 69, 341–344. [Google Scholar] [CrossRef] [Green Version]
- Nagel, M.A.; Gilden, D.H. The protean neurologic manifestations of varicella-zoster virus. Clevel. Clin. J. Med. 2007, 74, 489–504. [Google Scholar] [CrossRef]
- Kennedy, P.G.E. Neurological complications of varicella-zoster virus infections. In Infections of the Nervous System; Kennedy, P.G.E., Johnson, R.T., Eds.; Butterworths: London, UK, 1987; pp. 177–208. [Google Scholar]
- Gilden, D.H.; Cohrs, R.J.; Mahalingam, R. VZV vasculopathy and postherpetic neuralgia: Progress and perspective on antiviral therapy. Neurology 2005, 64, 21–25. [Google Scholar] [CrossRef]
- Kennedy, P.G.E.; Montague, P.; Scott, F.; Grinfeld, E.; Ashrafi, G.H.; Breuer, J.; Rowan, E.G. Varicella-zoster viruses associated with postherpetic neuralgia induce sodium current density increases in the ND7-23 Nav-1.8 neuroblastoma cell line. PLoS ONE. 2013, 8, e51570. [Google Scholar] [CrossRef] [Green Version]
- Oxman, M.; Levin, M.; Johnson, G.; Schmader, K.; Straus, S.; Gelb, L.; Arbeit, R.; Simberkoff, M.; Gershon, A.; Davis, L.; et al. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. N. Engl. J. Med. 2005, 352, 2271–2284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cunningham, A.L.; Lal, H.; Kovac, M.; Chlibek, R.; Hwang, S.-J.; Díez-Domingo, J.; Godeaux, O.; Levin, M.J.; McElhaney, J.E.; Puig-Barberà, J.; et al. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. N. Engl. J. Med. 2016, 375, 1019–1032. [Google Scholar] [CrossRef] [PubMed]
- Nagel, M.A.; Gilden, D. Update on Varicella Zoster Virus Vasculopathy. Curr. Infect. Dis. Rep. 2014, 16, 407. [Google Scholar] [CrossRef] [Green Version]
- Kennedy, P.G.E. Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV). Neurotherapeutics 2016, 13, 509–513. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nagel, M.A.; Forghani, B.; Mahalingam, R.R.; Wellish, M.C.; Cohrs, R.J.; Russman, A.N.; Katzan, I.; Lin, R.; Gardner, C.J.; Gilden, D.H. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 2007, 68, 1069–1073. [Google Scholar] [CrossRef] [PubMed]
- Gilden, D.; White, T.; Khmeleva, N.; Heintzman, A.; Choe, A.; Boyer, P.J.; Grose, C.; Carpenter, J.E.; Rempel, A.; Bos, N.; et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 2015, 84, 1948–1955. [Google Scholar] [CrossRef] [Green Version]
- Nagel, M.A.; White, T.; Khmeleva, N.; Rempel, A.; Boyer, P.J.; Bennett, J.L.; Haller, A.; Lear-Kaul, K.; Kandasmy, B.; Amato, M.; et al. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. JAMA Neurol. 2015, 72, 1281–1287. [Google Scholar] [CrossRef]
- Nordborg, C.; Nordborg, E.; Petursdottir, V.; LaGuardia, J.; Mahalingam, R.; Wellish, M.; Gilden, D.H. Search for varicella zoster virus in giant cell arteritis. Ann. Neurol. 1998, 44, 413–414. [Google Scholar] [CrossRef]
- Kennedy, P.G.E.; Grinfeld, E.; Esiri, M.M. Absence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis. J. Neurol. Sci. 2003, 215, 27–29. [Google Scholar] [CrossRef]
- Buckingham, E.M.; Foley, M.A.; Grose, C.; Syed, N.A.; Smith, M.E.; Margolis, T.P.; Thurtell, M.J.; Kardon, R. Identification of Herpes Zoster-Associated Temporal Arteritis Among Cases of Giant Cell Arteritis. Am. J. Ophthalmol. 2018, 187, 51–60. [Google Scholar] [CrossRef] [Green Version]
- Pisapia, D.J.; Lavi, E. VZV, temporal arteritis, and clinical practice: False positive immunohistochemical detection due to antibody cross-reactivity. Exp. Mol. Pathol. 2016, 100, 114–115. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, P.G.; Lipton, H.L. Varicella-zoster virus claims yet another painful scalp—Giant cell arteritis. Neurology 2015, 84, 1918–1919. [Google Scholar] [CrossRef] [PubMed]
- Ostrowski, R.A.; Metgud, S.; Tehrani, R.; Jay, W.M. Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature. Neuroophthalmology 2019, 43, 159–170. [Google Scholar] [CrossRef] [PubMed]
- Gilden, D.; Nagel, M.A.; Cohrs, R.J. Varicella-zoster. Handb. Clin. Neurol. 2014, 123, 265–283. [Google Scholar] [PubMed]
- Gilden, D.H.; Wright, R.R.; Schneck, S.A.; Gwaltney, J.M., Jr.; Mahalingam, R. Zoster sine herpete, a clinical variant. Ann. Neurol. 1994, 35, 530–533. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, P.G. Zoster sine herpete: It would be rash to ignore it. Neurology 2011, 76, 416–417. [Google Scholar] [CrossRef]
- Islam, B.; Islam, Z.; GeurtsvanKessel, C.H.; Jahan, I.; Endtz, H.P.; Mohammad, Q.D.; Jacobs, B.C. Guillain-Barré syndrome following varicella-zoster virus infection. Eur. J. Clin. Microbiol. Infect. Dis. 2018, 37, 511–518. [Google Scholar] [CrossRef] [Green Version]
- Horten, B.; Price, R.W.; Jimenez, D. Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster. Ann. Neurol. 1981, 9, 251–266. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kennedy, P.G.E. The Spectrum of Neurological Manifestations of Varicella–Zoster Virus Reactivation. Viruses 2023, 15, 1663. https://doi.org/10.3390/v15081663
Kennedy PGE. The Spectrum of Neurological Manifestations of Varicella–Zoster Virus Reactivation. Viruses. 2023; 15(8):1663. https://doi.org/10.3390/v15081663
Chicago/Turabian StyleKennedy, Peter G. E. 2023. "The Spectrum of Neurological Manifestations of Varicella–Zoster Virus Reactivation" Viruses 15, no. 8: 1663. https://doi.org/10.3390/v15081663